SwanBio Therapeutics, a gene therapy company, has named Steven Zelenkofske, DO, MS as its new chief medical officer, it was reported on Monday.
Dr Zelenkofske has over 20 years of experience. Prior to joining SwanBio Therapeutics, he served as the CMO at Achillion Pharmaceuticals and at UniQure. He has held leadership positions at Regado Biosciences, Astra-Zeneca, Sanofi-Aventis, Boston Scientific and Novartis. His work includes various therapeutic areas including neurology, immunology, haematology, cardiovascular, metabolic diseases, diabetes, and nephrology.
Tom Anderson, CEO and director of SwanBio Therapeutics, said, 'We are thrilled to add Steven's expertise to our leadership team. His background complements the extensive talent and experience of our existing management team and will help support our goal of developing gene therapies in neurological diseases that deliver real benefit to patients and their families.'
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer